<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="905">
  <stage>Registered</stage>
  <submitdate>2/10/2005</submitdate>
  <approvaldate>2/10/2005</approvaldate>
  <nctid>NCT00232232</nctid>
  <trial_identification>
    <studytitle>Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia</studytitle>
    <scientifictitle />
    <utrn />
    <trialacronym />
    <secondaryid>2003.074</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Atrial Fibrillation</healthcondition>
    <healthcondition>Atrial Flutter</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Fish oil

No Intervention: Control - No fish oil

Experimental: Fish oil - Patients prescribed 6g/day of fish oil containing 1.8g EPA+DHA in a 1.5:1 ratio


Treatment: drugs: Fish oil


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The extent of left atrial stunning in fish oil group compared to control after reversion of atrial arrhythmias to sinus rhythm.</outcome>
      <timepoint>18 months</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Chronic atrial flutter requiring radiofrequency ablation.

          -  Chronic atrial fibrillation requiring internal cardioversion.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-  Sinus rhythm.

          -  Pregnancy.

          -  Patients &gt; 80 years and &lt; 18 years of age</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/09/2003</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/11/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Royal Melbourne Hospital - Melbourne</hospital>
    <postcode>3050 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Melbourne Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to investigate whether fish oils may be of benefit to patients
      with certain heart rhythm disturbances called atrial fibrillation and atrial flutter.

      Atrial fibrillation and atrial flutter are two heart conditions that can be successfully
      treated in the hospital by an ablation (in the case of atrial flutter) or a cardioversion (in
      the case of atrial fibrillation). Ablation involves the application of high frequency energy
      waves to a particular spot in the heart. Cardioversion involves resetting the heart back to a
      normal rhythm with the use of an electric current.

      Fish oil supplements may be of benefit to patients with heart problems. Recent evidence
      suggests that fish oils may benefit those with rhythm disturbances.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00232232</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Paul Sparks</name>
      <address>Melbourne Health</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>